Abstract:Cellular senescence is a hallmark of normal aging and aging-related syndromes, including the premature aging disorder Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic disorder caused by a single mutation in the LMNA gene that results in the constitutive expression of a truncated splicing mutant of lamin A known as progerin. Progerin accumulation leads to increased cellular stresses including unrepaired DNA damage, activation of the p53 signaling pathway and accelerated senescence. We previously established that the p53 isoforms ∆133p53 and p53β regulate senescence in normal human cells. However, their role in premature aging is unknown. Here we report that p53 isoforms are expressed in primary fibroblasts derived from HGPS patients, are associated with their accelerated senescence and that their manipulation can restore the replication capacity of HGPS fibroblasts. We found that in near-senescent HGPS fibroblasts, which exhibit low levels of ∆133p53 and high levels of p53β, restoration of Δ133p53 expression was sufficient to extend replicative lifespan and delay senescence, despite progerin levels and abnormal nuclear morphology remaining unchanged. Conversely, Δ133p53 depletion or p53β overexpression accelerated the onset of senescence in otherwise proliferative HGPS fibroblasts. Our data indicate that Δ133p53 exerts its role by modulating full-length p53 (FLp53) signaling to extend the replicative lifespan and promotes the repair of spontaneous progerin-induced DNA double-strand breaks (DSBs). We showed that Δ133p53 dominant-negative inhibition of FLp53 occurs directly at the p21/CDKN1A and miR-34a promoters, two p53 senescence-associated genes. In addition, Δ133p53 expression increased the expression of DNA repair RAD51, likely through upregulation of E2F1, a transcription factor that activates RAD51, to promote repair of DSBs. In summary, our data indicate that Δ133p53 modulates p53 signaling to repress progerin-induced early onset of senescence in HGPS cells. Therefore, restoration of ∆133p53 expression may be a novel therapeutic strategy to treat aging-associated phenotypes of HGPS in vivo.

Rapid Senescence Induced by Overexpression of P53 in NIH3T3 Cells

Senescence-like Changes Induced by Expression of P21waf1/cip1 in NIH3T3 Cell Line

SENP3 Postpones Cellular Senescence of P53-mediated Pathway under Mild Oxidative Stress

[Effect of Wt P53 Gene Transfection on Sensitivity of Hyperthermia in C6 Glioma Cells].

p53 mutant mice that display early ageing-associated phenotypes

Gain-of-Function p53N236S Mutation Drives the Bypassing of HRasV12-Induced Cellular Senescence via PGC–1α

Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging

p53 isoforms regulate premature aging in human cells

p53 Protects Cells from Death at the Heatstroke Threshold Temperature.

Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition

Adenoviruses-mediated Over-Expression of p33~(ING1B) Promotes UV-Induced Apoptosis in Senescent Fibroblasts

p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming

Cellular adaptation to hypoxia and p53 transcription regulation

p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage

Role of p53 in the Regulation of Cellular Senescence

A Switch-Like Dynamic Mechanism for the Initiation of Replicative Senescence

Adenoviruses-mediated Overexpression of p33 ~(ING1b) Dramatically Enhances DNA Damage Repair in Senescent Cells

p52 signaling promotes cellular senescence

The P53/mirnas/ccna2 Pathway Serves As a Novel Regulator of Cellular Senescence: Complement of the Canonical P53/p21 Pathway

P53, Oxidative Stress, and Aging